Results 181 to 190 of about 1,154,939 (343)
Coronary artery bypass grafting: Part 1--the evolution over the first 50 years.
S. Head +4 more
semanticscholar +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Isolated iron deficiency in off-pump coronary artery bypass grafting. [PDF]
Ju JW.
europepmc +1 more source
Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospects.
S. Head +8 more
semanticscholar +1 more source
Abstract Background and Purpose Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CM) have gained interest as a pharmacological model but their immaturity leads to uncertainty regarding translation. We studied the key player in maintaining ionic homeostasis, the Na+/K+‐ATPase (NKA), in hiPSC‐CM.
Djemail Ismaili +16 more
wiley +1 more source
Orthotopic Heart Transplantation with Concurrent Coronary Artery Bypass Grafting Using In Situ Internal Thoracic Artery. [PDF]
Verma A +7 more
europepmc +1 more source
A Case of Progressing Stroke treated with a "Hemi-bonnet Bypass" A3-RA Graft-STA Anastomosis
Kojiro Wada +8 more
openalex +2 more sources
ABSTRACT Background Primary aldosteronism (PA) has been linked with reduced health‐related quality of life (QoL) and increased prevalence of anxiety and depression. While most studies compared patients with PA to healthy subjects, this study focused on comparison with hypertensive patients without PA to identify PA‐specific effects.
Sybille Fuld +15 more
wiley +1 more source

